Moods Disorders Completed Phase 4 Trials for Olanzapine (DB00334)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02593734Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaTreatment